Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.

Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S. · 2021

Read Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. by Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8067447.txt.

Description

Yadav and co-authors review the proteins of SARS-CoV-2 and the drug targets they offer. The virus carries a positive-sense RNA genome of 26 to 32 kilobases. Its spike binds the human ACE2 receptor with 10 to 20 times the grip of the older SARS virus. Entry proteases then cut the spike to open the cell. Inside, two large polyproteins are translated first.

Those polyproteins are chopped into the working machinery of the virus. Its replicase copies the genome and prints nested sets of messages. Structural proteins then build new virus particles around fresh genomes. The review walks through each protein's job in that cycle. It sorts the best points of attack for drug design. Convalescent plasma therapy gets a section as well. Candidate vaccines close the survey of defenses.

Catalog record

CREATORYadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8067447

Browse the full library · About the Tower of Babel